Department of Surgery, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts 02129, USA.
Biol Blood Marrow Transplant. 2012 Nov;18(11):1629-37. doi: 10.1016/j.bbmt.2012.08.004. Epub 2012 Aug 11.
Loss of chimerism is an undesirable outcome of allogeneic hematopoietic cell transplantation (HCT) after reduced-intensity conditioning. Understanding the nature of cellular and humoral immune responses to HCT after graft loss could lead to improved retransplantation strategies. We investigated the immunologic responses after graft loss in miniature swine recipients of haploidentical HCT that received reduced-intensity conditioning. After the loss of peripheral blood chimerism, antidonor cellular responses were present without detectable antidonor antibody. Reexposure to donor hematopoietic cells after graft loss induced a sensitized antidonor cellular response. No induced antidonor antibody response could be detected despite evidence of cellular sensitization to donor cells. In contrast, unconditioned animals exposed repeatedly to similar doses of haploidentical donor cells developed antidonor antibody responses. These results could have important implications for the design of treatment strategies to overcome antidonor responses in HCT and improve the outcome of retransplantation after graft loss.
嵌合状态的丢失是所有经过减强度预处理的异基因造血细胞移植(HCT)的不良后果。了解移植物丢失后细胞和体液免疫反应的性质可能会导致改进的再移植策略。我们研究了在接受减强度预处理的半同基因 HCT 的小型猪受者中移植物丢失后的免疫反应。在外周血嵌合体丢失后,存在针对供体的细胞反应,而没有检测到针对供体的抗体。移植物丢失后再次暴露于供体造血细胞会引起致敏的针对供体的细胞反应。尽管存在对供体细胞的细胞致敏的证据,但未检测到诱导的针对供体的抗体反应。相比之下,未经过预处理的动物反复暴露于类似剂量的半同基因供体细胞会产生针对供体的抗体反应。这些结果可能对设计治疗策略以克服 HCT 中的抗供体反应并改善移植物丢失后的再移植结果具有重要意义。